HOSPIRA UK LIMITED

Active Tadworth

Manufacture of basic pharmaceutical products

0 employees website.com
Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparations +1
H

HOSPIRA UK LIMITED

Manufacture of basic pharmaceutical products

Founded 18 Jun 1985 Active Tadworth, England 0 employees website.com
Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsWholesale of pharmaceutical goods

Previous Company Names

FAULDING PHARMACEUTICALS PLC 7 Feb 1990 — 28 Nov 2002
F.H. FAULDING (U.K.) LIMITED 31 Jul 1985 — 7 Feb 1990
HILLMAST LIMITED 18 Jun 1985 — 31 Jul 1985
Accounts Submitted 5 Aug 2025 Next due 31 Aug 2026 3 months remaining
Confirmation Submitted 17 Nov 2025 Next due 23 Nov 2026 6 months remaining
Net assets £135K £18K 2024 year on year
Total assets £135K £519K 2024 year on year
Total Liabilities £0 £537K 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

Walton Oaks Walton-On-The-Hill Dorking Road Tadworth Surrey KT20 7NS England

Full company profile for HOSPIRA UK LIMITED (01923357), an active company based in Tadworth, England. Incorporated 18 Jun 1985. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£135.00k

Increased by £18.00k (+15%)

Total Liabilities

N/A

Decreased by £537.00k (-100%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 82 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
David Ian HightonDirectorBritishEngland578 Feb 2021Active

Shareholders

Shareholders (1)

Pfizer Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Pfizer Limited

United Kingdom

Active
Notified 1 Apr 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Pfizer Pfe Uk Limited

Ceased 1 Apr 2018

Ceased

Group Structure

Group Structure

PFIZER LIMITED united kingdom
HOSPIRA UK LIMITED Current Company

Charges

Charges

2 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Unit 1, Tachbrook Road, Leamington Spa WARWICK
Leasehold-25 Mar 1998
Unit 1, Tachbrook Road, Leamington Spa
Leasehold
Added 25 Mar 1998
District WARWICK

Documents

Company Filings

DateCategoryDescriptionDocument
17 Nov 2025Confirmation StatementConfirmation statement made on 9 Nov 2025 with no updates
5 Aug 2025AccountsAnnual accounts made up to 30 Nov 2024
20 Nov 2024OfficersAppointment of Mr David Highton as director
19 Nov 2024Confirmation StatementConfirmation statement made on 9 Nov 2024 with updates
8 Oct 2024OfficersTermination of Susan Rienow as director on 8 Oct 2024
17 Nov 2025 Confirmation Statement

Confirmation statement made on 9 Nov 2025 with no updates

5 Aug 2025 Accounts

Annual accounts made up to 30 Nov 2024

20 Nov 2024 Officers

Appointment of Mr David Highton as director

19 Nov 2024 Confirmation Statement

Confirmation statement made on 9 Nov 2024 with updates

8 Oct 2024 Officers

Termination of Susan Rienow as director on 8 Oct 2024

Recent Activity

Latest Activity

Confirmation statement made on 9 Nov 2025 with no updates

5 months ago on 17 Nov 2025

Annual accounts made up to 30 Nov 2024

9 months ago on 5 Aug 2025

Appointment of Mr David Highton as director

1 years ago on 20 Nov 2024

Confirmation statement made on 9 Nov 2024 with updates

1 years ago on 19 Nov 2024

Termination of Susan Rienow as director on 8 Oct 2024

1 years ago on 8 Oct 2024